Loading provider…
Loading provider…
Hematology & Oncology Physician in Berkeley, CA
NPI: 1104844174Primary Practice Location
ALTA BATES SUMMIT MEDICAL CENTER - ALTA BATES CAMP
2450 Ashby Ave, Berkeley, CA
Primary Employer
Epic Care
epic-care.com
HQ Phone
Get M.D. Rajesh's Phone Numberphone_androidMobile
Get M.D. Rajesh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
CA State Medical License
2006 - 2025
MA State Medical License
2005 - 2007

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Washington University/B-JH/SLCH Consortium
Fellowship • Hematology and Medical Oncology
1998 - 2001
University of Minnesota
Residency • Internal Medicine
1995 - 1998
Maulana Azad Medical College
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 404 | 1,268 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 212 | 349 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 146 | 350 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 86 | 601 |
| 5 | 38221Needle or trocar bone marrow biopsy | 63 | 73 |
Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase–neo cassette located between the murine β-major and β-minor globin genes
Authors: Richard M. Kaufman, Zhi Hong Lu, Rajesh Behl, Jo M. Holt, Gary K. Ackers
Authors: Benjamin Djulbegovic
Journal: Biol Blood Marrow Transplant
Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions.
Authors: Paula A. Revell, William Grossman, Dori A. Thomas, Xuefang Cao, Rajesh Behl
Lead Sponsor: Genmab
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Rituximab, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Epcoritamab, DRUG: Vincristine